Bausch Health
315 hedge funds and large institutions have $4.49B invested in Bausch Health in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 102 increasing their positions, 98 reducing their positions, and 48 closing their positions.
1.23% more ownership
Funds ownership: 57.33% → 58.56% (+1.2%)
4% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 98
5% less funds holding
Funds holding: 332 → 315 (-17)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
11% less capital invested
Capital invested by funds: $5.04B → $4.49B (-$547M)
31% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 48
43% less call options, than puts
Call options by funds: $242M | Put options by funds: $425M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$93.7M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$62M |
| 3 |
RA
Rovida Advisors
Fort Lauderdale,
Florida
|
+$48.6M |
| 4 |
Renaissance Technologies
New York
|
+$46.3M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$59.8M |
| 2 |
Two Sigma Advisers
New York
|
-$37.7M |
| 3 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$37.5M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$24.1M |
| 5 |
GAM
Goldentree Asset Management
New York
|
-$23.5M |
BHC Hedge Fund Activity: Q3 2019 in Review
315 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2019, worth a combined $4.49B — down 11% from $5.04B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of BHC and 33 opened new positions — a net loss of 15 holders — while 98 trimmed existing stakes and 102 added.
The largest buyer was Glenview Capital Management, adding an estimated $93.7M. The largest seller was Wellington Management Group, cutting an estimated $59.8M.
- 315 institutional investors held Bausch Health (BHC) as of Q3 2019, down from 332 in Q2 2019.
- Funds reported $4.49B of Bausch Health stock for Q3 2019, down 11% quarter-over-quarter.
- 33 funds opened new Bausch Health positions in Q3 2019 and 48 closed out, a net change of -15 holders.
- The largest Bausch Health buyer in Q3 2019 was Glenview Capital Management, an estimated $93.7M added.
- The largest Bausch Health seller in Q3 2019 was Wellington Management Group, an estimated $59.8M sold.
Based on aggregated 13F filings for Q3 2019.